Author:
Farah J.,Mares V.,Romero-Expósito M.,Trinkl S.,Domingo C.,Dufek V.,Klodowska M.,Kubancak J.,Knežević Ž.,Liszka M.,Majer M.,Miljanić S.,Ploc O.,Schinner K.,Stolarczyk L.,Trompier F.,Wielunski M.,Olko P.,Harrison R. M.
Reference49 articles.
1. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age;Zacharatou-Jarlskog;Int. J. Radiat. Oncol., Biol., Phys.,2008
2. Assessing the risk of second malignancies after modern radiotherapy;Newhauser;Nat. Rev. Cancer,2011
3. Evaluation of risk of secondary cancer occurrence after proton radiotherapy of ocular tumours;Stolarczyk;Radiat. Meas.,2011
4. Relative biological effectiveness, radiation weighting and quality factor;International Commission on Radiological Protection;Ann. ICRP,2003
5. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field;Yan;Nucl. Instrum. Methods Phys. Res., Sect. A,2002
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献